Bruker announces the appointment of Dr. René Lenggenhager as President of the Bruker BioSpin Group, effective November 1st, 2015. René has over 25 years of management experience in international high-tech companies and in the scientific instruments industry, where his responsibilities have included general management with P&L responsibility for a global business, marketing, R&D and global operations. René has extensive experience with complex transformations, operational excellence, lean manufacturing, marketing and value selling. Moreover, René has a very successful track record in sustainable, profitable growth with a focus on customers and innovation.Since 2004, Dr. Lenggenhager has served as General Manager for Laboratory Weighing at METTLER TOLEDO (MTD). From 2000 until 2003, he was the Head of R&D of Laboratory & Weighing Technologies at MTD. Previously, he worked at the Siemens Building Technologies SBT Cerberus Division, at Cerberus AG, at Landis & Gyr AG and at Metrohm AG. René holds a Ph.D. in physics from the Swiss Federal Institute of Technology (ETH), Zurich, a Bachelor of Science in electronics from the University of Applied Sciences NTB, Buchs, and an Executive MBA from University of St. Gallen, all in Switzerland.Frank Laukien, President and CEO of Bruker Corporation, said: “I am very pleased to welcome René to Bruker. His success in our industry, his broad technical background, and his passion for innovation and customers are impressive. His outstanding track record with operational excellence, profitable growth and margin enhancement make René a compelling Group President to lead Bruker BioSpin to the next level.”Dr. René Lenggenhager commented: “Bruker has a strong reputation for excellence in the customer community, with high-performance instruments and high-value analytical solutions. Bruker BioSpin is making progress with its transformation and recent new product launches, and I am excited to join this creative team to drive profitable growth and value for our customers and shareholders. I am committed to business success and to providing the best solutions to make our customers successful, and to develop new applications that will improve the quality of human life.”
Read More>>Plastics. Computers. Metamaterials?Almost half a century after Dustin Hoffman was taken aside in “The Graduate” and given the famous “one word” line about the future, it may be time to update the script again. And metamaterials appear to have the same potential to transform entire industries. Over the past 15 years or so, scientists have learned how to construct materials that bend light waves, as well as radar, radio, sound and even seismic waves, in ways that do not naturally occur.First theorized in 1967 by the Russian physicist Victor Veselago and invented in 1999 by a group led by the physicist David R. Smith, the new design approach was first seen as a curiosity that hinted at science fiction applications like invisibility cloaks.But today, researchers have gained a better understanding of the science and are generating innovations in an array of fields, including radio antennas, radar, cosmetics, soundproofing and walls that help protect against earthquakes and tsunamis.Last year, the aircraft manufacturer Airbus announced that it was joining with Lamda Guard, a Canadian company, to test a metamaterial-based coating for cockpit windows to protect pilots in commercial aircraft from being blinded by laser pointers.A key innovation behind metamaterials is that they are constructed with subcomponents that are smaller than the wavelength of the type of radiation they are designed to manipulate. The precise, often-microscopic patterns can then be used to manipulate the waves in unnatural ways.The implications of these new materials can be seen in two prototype radar antennas being designed at Echodyne, a start-up firm here that has been funded with backing from Bill Gates, a Microsoft co-founder, and Madrona Venture Group.There are obvious markets for the technology in automotive safety and self-driving cars. Google’s advanced experimental vehicles use a costly mechanical laser-based device called a lidar to create an instantaneous high-resolution map of objects around the car. Based on a rapidly spinning laser, Google’s lidars still cost roughly $8,000. The radars being designed by Echodyne may soon be able to create similar maps at a much lower cost.Echodyne is the third metamaterials company to be spun out of Intellectual Ventures, an investment and patent firm created by Nathan Myhrvold, a physicist who was Microsoft’s chief technology officer. Two other firms, Kymeta and Evolv Technology, are working on other metamaterial-based applications.Evolv is pursuing higher-performance airport-security-scanning technology, and Kymeta recently announced a partnership with Intelsat to design land-based and satellite-based intelligent antennas that would greatly increase the capacity and speed of next-generation satellite Internet services.Xiang Zhang, a professor of mechanical engineering at the University of California, Berkeley, runs a laboratory that has pioneered a number of applications for metamaterials, including so-called optical “superlenses” that may one day surpass the power of today’s microscopes.Dr. Zhang says he hears from many military contractors and commercial companies that are interested in pursuing metamaterial applications.Several years ago, he said, he received several calls from what he thought was Loral Space & Communications, a military contractor. He then learned that the caller was the French cosmetics and beauty firm L’Oréal, which was interested in metamaterials that might be used to change appearance or to create a more effective sunblock.Dr. Zhang and others are pursuing applications that could drastically lower the cost and increase the performance of optical computer networks.In 2012, the Berkeley Nanosciences and Nanoengineering Institute published a paper with South Korean scientists describing a metamaterial-based electro-optical modulator made from a sheet of graphene just a single atom thick that was able to switch lightwaves at terahertz frequencies.More recently, a group at City College of New York, led by the physicist Vinod Menon, demonstrated light emission from ultrafast-switching LEDs based on metamaterials. Together, such innovations could make possible optical computer networks far faster than today’s gigabit networks.Indeed metamaterials are still finding their way into new fields. Papers have recently been published that explore the idea of using metamaterial-based “walls” to dampen the seismic waves in earthquakes or the effects of tsunamis.In 2013, scientists at the French construction firm Menard published a paper on arxiv.org, an automated electronic archive for research articles, describing a test of a novel way of counteracting the effects of an earthquake from a metamaterial grid of empty cylindrical columns bored into soil. They reported that they were able to measure a significant dampening of a simulated earthquake with the array of columns.New applications for metamaterials are certain to emerge in coming years, Dr. Zhang said.“It’s beyond our imagination right now,” he said. “But we will push the frontiers.”
Read More>>ASHG 2015–Life scientists whowork with DNA, RNA and proteins can make educated decisions about samplesuitability in experiments using a standalone, microvolume spectrophotometerfor accurate quantitation and purity measurements to ensure downstreamapplication success. Thermo Fisher Scientific will be showcasing the NanoDropOne and NanoDrop OneC this week at theupcoming 65th Annual Meeting of the American Societyof Human Genetics (ASHG), taking place in Baltimore, Maryland, October 6-10,2015, Booth #1415.“Building on the success of previous NanoDropinstruments, used by thousands of scientists worldwide, we have designed theNanoDrop One instrument to provide simplicity and speed as well as informationon sample quality”The ThermoScientific NanoDrop One and NanoDrop OneC UV-Vis microvolumespectrophotometers are designed to help life science researchers gain amore complete understanding of sample quality and avoid costly delays due totroubleshooting and repeating experiments. These new spectrophotometersintroduce the Thermo Scientific Acclaro Sample Intelligence technology, whichenables researchers to:· Identify sample contaminants and obtain correctedconcentration results;· Receive instant feedback about sample quality withon-demand technical support and guided troubleshooting; and· Confidently measure samples with embedded sensor anddigital image analysis.“Building on thesuccess of previous NanoDrop instruments, used by thousands of scientistsworldwide, we have designed the NanoDrop One instrument to provide simplicityand speed as well as information on sample quality,” said Dr. Voula Kodoyianni,product manager, molecular spectroscopy, Thermo Fisher. “This allows scientiststo accurately quantify and qualify nucleic acid and protein samples, so theycan make informed decisions on sample use in downstream applications.”The NanoDrop Oneinstrument with its high-resolution, touchscreen interface makes it simple touse as a compact, ergonomic instrument, while the powerful auto-rangepathlength technology facilitates accurate measurements for concentratedsamples with no need for dilutions.The patented NanoDropsample-retention system measures 1-2 µL of sample in seconds without the needfor cuvettes, making it a cost- and time-effective solution for busy labs.Workflows can be streamlined on the NanoDrop One instrument with theAuto-Measure functionality, while modern connectivity allows results to beshared and archived via Wi-Fi, Ethernet or USB. The NanoDrop OneC instrument containsboth pedestal and cuvette measuring positions, increasing dynamic range andassay flexibility.
Read More>>Intertek, a leadingquality solutions provider to industries worldwide, today announced theexpansion of its analysis services (polymer degradation) for the medical device industry and its suppliers.“Intertek engineers and scientists in combination with abroad array of analytical problem solving tools are available to respond to ourcustomers’ questions relating to polymer degradation, helping them to optimisethe performance of the medical device”Many key components of medical devices are made from polymer materials. The stability or degradationcharacteristics of a polymer are key attributes in evaluating how suitable theyare for use in a device as they can impact device performance. Controlledpolymer degradation is desired for drug release in a drug delivery systemwhereas, in contrast, degradation of a polymer component in a catheter, forexample, can trigger a mechanical failure. For each function, it is importantto fully understand the polymer material and the changes that can lead todegradation through study with a combination of analytical techniques.Intertek have recentlyexpanded polymer analysis capabilities through investment in advanced polymerchromatography with fraction collection (SEC-APC) and advanced analysis bymatrix assisted laser desorption ionization mass spectrometry (MALDI-MS). Thesenew capabilities augment the existing broad array of polymer analysis toolswhich include size exclusion chromatography to evaluate polymer molecularweight and techniques to determine rheology, thermal degradation and structuralidentification.Clients will benefitas they can access, through Intertek’s expertise, a full understanding ofpolymer materials and polymer degradation. This knowledge can assist in theearly detection of polymer failure, help clients to monitor raw materiallot-to-lot variability in relation to product performance. Learn more aboutthese techniques and related services at the upcoming MD&M Philadelphia,October 7-8, Booth 513.“Intertek engineersand scientists in combination with a broad array of analytical problem solvingtools are available to respond to our customers’ questions relating to polymerdegradation, helping them to optimise the performance of the medical device,”states Dr. Paula McDaniel, Business Development Director at Intertek.Intertek’s polymertesting laboratories in Allentown (United States of America), Basel(Switzerland), Geleen (Netherlands) and Wilton (United Kingdom) have workedwith innovators in the polymer industry and industries that use polymers suchas medical devices for over 20 years. Intertek polymer engineers, chemists andregulatory experts work with clients to optimise polymer development andenhance performance through advanced analytics, problem solving and pilot plantprocessing facilities.
Read More>>Bruker announced that its NMR FoodScreener?laboratory for food authenticity and quality determination, located in Rheinstetten,Germany, has been granted ISO/IEC 17025 accreditation. The certificate has beenawarded for Bruker’s validated methods for the determination of ingredients andmeasures of authenticity and quality of liquid foods and food extracts by NMRspectroscopy. Government and private analytical service laboratories offeringNMR-based testing for food authenticity and quality with Bruker’s standardoperating procedures (SOPs) and validated methods can now more easily get theseNMR methods accredited in their lab.“We are excited that theISO/IEC 17025 accreditation has been achieved. NMR now delivers certifiedmethods for targeted, as well as non-targeted food screening. For food analysisthis enables the identification of unexpected and unknown deviations andfalsifications that can highlight processing issues, frauds or adulterations.”Christian Kost,Managing Director of Winespin-Analytics GmbH, commented: “As a companyproviding NMR-based analytical wine profiling, the ISO/IEC 17025 accreditationof Bruker is of significant importance, allowing us to now offer accredited NMRwine profiling according to international standards to our customers. Theaccreditation represents a milestone towards NMR becoming a more widely usedtechnique for wine analysis, enabling us to offer this unique, information-richtechnique to a broader set of wine industry customers.”All of Bruker’scurrent NMR food-screening applications for juice, wine and honey profiling arenow covered by this accreditation. Dr. Iris Mangelschots, President of BrukerBioSpin’s Applied, Industrial and Clinical (AIC) division, explained: “We areexcited that the ISO/IEC 17025 accreditation has been achieved. NMR nowdelivers certified methods for targeted, as well as non-targeted food screening.For food analysis this enables the identification of unexpected and unknowndeviations and falsifications that can highlight processing issues, frauds oradulterations.”
Read More>>Research conductedat Barts Cancer Institute, Queen Mary University, London, published today inPLOS ONE demonstrates that the Parsortix Cell Separation System from ANGLE plc,showed comparable speed – approximately two hours – in capturing circulatingtumor cells (CTCs) for prostate cancer compared to bead-based epithelial celladhesion molecule (EpCAM) antibody CTC capturing systems, while also showingimproved capture of CTCs that are responsible for metastatic cancer.“Understanding how molecularalterations in cancer cells change and evolve during cancer progression and inresponse to first-line therapeutics is vital to better understanding cancerprogression and improving how we care for patients with metastatic disease”The research teamled by Dr. Yong-Jie Lu at Barts developed an optimized sample preparationmethod for the capture of CTCs from blood samples from patients with prostatecancer and healthy blood samples spiked with prostate cancer cells. Theirresearch demonstrated that employing their method allowed the Parsortix systemto process samples at a speed and sample volumes comparable to the standardCellSearch system typically used in the clinical setting, while alsodemonstrating the ability to harvest CTCs not only with epithelial features,but also those in the process of, or that had completed,epithelial-to-mesenchymal transition (EMT) – a significant finding that willprovide more information for the detection and treatment of metastatic cancer.“Understanding howmolecular alterations in cancer cells change and evolve during cancerprogression and in response to first-line therapeutics is vital to betterunderstanding cancer progression and improving how we care for patients withmetastatic disease,” said Andrew Newland, CEO of ANGLE, plc. “However, currentbead-based EpCAM antibody CTC capturing systems have a critical limitation.During cancer metastasis, EMT occurs to increase the invasion capability ofcancer cells, which leads to the loss of epithelial markers, such as EpCAM andtheir replacement with mesenchymal markers. The Parsortix microfluidic systemcaptures CTCs based on their size and deformability – not cell membraneexpressed proteins – and can capture the cells that have completed EMT to allowfor more precise monitoring of cancer progression.”Currently, CTCisolation is still mainly based on EpCAM expression on epithelial origin cancercells. New research, however, indicates EMT is more and more recognized to playan important role in metastasis and that certain EMT cancer cells lose EpCAMexpression. Isolation by techniques that are independent of marker expression,such as Parsortix, may help to capture those EMT CTCs.CTC clusters havebeen reported to have increased metastatic potential, be more resistant toapoptosis and be correlated with poorer prognosis compared to single CTCs. InParsortix isolated samples, the researchers also observed clusters of more thanthree CTCs. The ability to obtain CTC clusters will help to understand themetastasis progenitor and to predict patient prognosis.The Bartsresearchers used prostate cancer as a cancer model to optimize and evaluate theParsortix size and deformability-based system for CTC isolation and comparedits efficiency with two other leading CTC systems, IsoFlux from FluxionBiosciences and CellSearch from Janssen DX. Based on the current generallyaccepted definition of CTCs as CK positive, CD45 negative, nucleated andmorphologically intact cells, CellSearch harvested the least CTCs among thethree platforms, while the number of CTCs harvested by IsoFlux and Parsortixshowed no statistically significant difference. Parsortix, however, showedsignificantly higher purity of harvested CTCs compared to IsoFlux, which makesdownstream analysis easier.The research alsoindicates that employing Parsortix can avoid potential problems in downstreamanalysis of CTCs caused by the magnetic beads used by CellSearch and IsoFlux.“For example, inimmunofluorescence analysis, beads adhering to the cell membrane and coveringon the top of the cells prohibits effective immunostaining for membraneproteins,” said lead researcher Yong-Jie Lu. “Auto-fluorescence from the beadsalso affects CTC analysis using fluorescence markers, such asimmunofluorescence and fluorescence in situ hybridization. The bead-freesystems avoid these problems in downstream CTC analysis.”“The easy to use,epitope-independent Parsortix system not only captures clinically-relevant CTCsof all different phenotypes but it allows their easy harvesting for downstreamanalysis. Furthermore the cells are undamaged and we have shown them to beviable for cell culture.”AboutANGLE plcANGLE is aUK-based specialist medtech company commercializing the Parsortix system, acell separation technology that enables a simple blood test to capture targetedcells, such as circulating tumor cells (CTCs) for molecular profiling andanalysis. Parsortix can help deliver targeted cancer diagnostics designed toinform personalized treatment of cancer. It is also designed to be compatiblewith existing major medtech analytical platforms and to act as a companiondiagnostic for major pharma in helping to identify patients that will benefitfrom a particular drug and then monitoring the drug’s effectiveness. ANGLE has establishedformal collaborations with world-class cancer centers and is working with thesecancer centers to demonstrate key applications for its Parsortix non-invasivecancer diagnostic system as a liquid biopsy. In addition to cancer cells, theParsortix technology has the potential for deployment for other clinicallysignificant cell types in the future. ANGLE’s Parsortixsystem is available for research use worldwide and is CE-IVDD Marked forindicated clinical use in Europe. The Company’s first clinical application isin ovarian cancer.
Read More>>Servomex, the world leader in gas analysis, has been awardedTier 1 status on the Linde Global Governance Critical Vendor List.Following a successful Analytics Symposium held at Linde’s head office in Munich, Germany, several Servomex analyzers have been fully approved for use in gas applications on Linde sites worldwide - without the need for additional testing or qualification.Chosen on the basis of the industry-leading quality, reliability and capability of Servomex’s analyzers and proprietary sensing technologies, three analyzers have been approved: The SERVOPRO MultiExact 5400 digital multigas analyzer, capable of providing percentage/trace (ppm) oxygen purity and ppm carbon dioxide (CO2) measurements; the SERVOPRO Chroma trace gas analyzer for measuring ppm O2, CO2, hydrogen (H2), nitrogen (N2) or methane (CH4) in Argon (Ar); and percent and ppm O2 measurements using DF-310 high-sensitivity digital O2 analyzer.Several additional MultiExact measurements for percent O2, trace CO and trace N2, plus a measurement for N2 in Ar using the SERVOPRO Plasma, have been awarded Tier Two status meaning they will undergo approval, laboratory testing and field trials.Servomex is also working closely with Linde to support further standardization of applications and to help qualify devices used in hydrocarbon processing, electronics manufacture and specialty gases production.“We are delighted and honored that Linde has awarded Tier One status to these Servomex analyzers,” said Patrick Hellberg, Global Linde Account Manager, Servomex. “We are focused not only on providing Linde the high quality, reliable and trustworthy measurement they demand, but also ensuring our ASU application experience and knowledge is available to help optimize Linde applications wherever it is required.”For more information about Servomex gas analysis solutions, visit www.servomex.com
Read More>>Bruker today announced five orders for ultra-high field (UHF) nuclear magnetic resonance (NMR) spectroscopy systems from Europe and Brazil in recent months. These UHF systems have been funded for cutting-edge NMR research in structural biology, intrinsically disordered proteins (IDPs), membrane proteins, macro-molecular complexes and interactions, cell biology, disease research, as well as in advanced materials research.“We are very happy to have placed the order for the next generation of NMR. The 1.2 GHz NMR system will allow us to investigate structure, dynamics and biological function of increasingly large and challenging biomolecular complexes. We will also be able to provide access for European researchers.”Bruker defines UHF as NMR systems with 1H proton frequency of 900 MHz or above. Other high-field 700, 800 and 850 MHz orders are not included in the UHF definition. The recent UHF NMR orders include three 900 and 950 MHz systems from Brazil, Switzerland and the UK, with revenue typically within 18 months from order:The Federal University of Rio de Janeiro (UFRJ) in Brazil is expanding its existing structural biology facility with the addition of a 900 MHz NMR spectrometer. As one of the leading universities in South America, the new 900 MHz system will be available as a regional resource for research in protein structure and dynamics, protein folding and structure of nucleic acids. Professor Fabio C. L. Almeida of UFRJ commented: "Having a 900 MHz will have a strong impact on the development of NMR and structural biology in Brazil and Latin America. It will offer us advantages and capabilities over other techniques in tackling important biological and technological problems."The École Polytechnique Féderale de Lausanne (EPFL) in Switzerland has ordered a Bruker 900 MHz instrument with the highest field wide-bore (89 mm inner diameter) magnet currently available for solid-state NMR. It will enable EPFL researchers to tackle problems in complex systems such as enzymes, catalytic nanoparticles, active pharmaceutical ingredients and live model organisms.The University of Leeds in the UK is expanding its Astbury Centre for Structural Molecular Biology with a 950 MHz NMR equipped with a novel CryoProbe that is now designed for both 13C and 15N direct detection, besides traditional 1H indirect detection. This technology makes the instrument suitable for determining structures, dynamics and interactions of globular proteins, as well as for advanced functional and disease mechanism studies of intrinsically disordered proteins (IDPs). Professor Alex Breeze at the University of Leeds stated: “We are tremendously excited to be installing our new 950 MHz instrument, which will complement our investment in cutting-edge cryo-electron microscopy and other structural techniques. In particular, the combination of 950 MHz field strength and the novel direct-detection and low-volume capabilities of the latest CryoProbes will allow us to access critical structural and dynamic information on important biological systems and medically relevant targets with the optimum sensitivity and resolution.”In 2015, Bruker also has received two additional orders for next-generation GHz-class systems from France and Germany, and Bruker’s backlog for GHz-class NMR systems has now increased to nine (9) systems for different European and Canadian customers. Bruker expects to begin to recognize revenues from next-generation Aeon? 1.0 GHz systems in 2016. The Aeon 1.2 GHz systems backlog is projected to ship over several years, starting in late 2017 or 2018. Revenue timing for future 1.2 GHz systems has inherent risks, and depends on further progress in high-temperature superconductor (HTS) materials and HTS-based NMR magnet technology.A 1.2 GHz instrument ordered by the CNRS is expected to be placed at the University of Lille in France and will be available to the French and European scientific community through the NMR Large Scale Facility, hosted by the Centre National de la Recherche Scientifique (CNRS). Dr. Jean-Pierre Simorre, Director of the Large Scale Facility, explained: “The acquisition of this 1.2 GHz spectrometer will keep France at the leading edge of NMR technology. This national instrument will be installed in Lille for a broad panel of interdisciplinary research areas ranging from structural biology to catalysis, from sustainable energy development to bio-medical applications.”The Center for Biomolecular Magnetic Resonance (BMRZ) at the Goethe University in Frankfurt, Germany is part of the European Large Scale Facilities and incorporates various high-field liquid and solid-state NMR spectrometers, as well as DNP-NMR and EPR instrumentation. The 1.2 GHz NMR ordered recently is expected to be available to the scientific community in Germany and Europe. Research at the BMRZ is dedicated to the elucidation of structure and functional mechanisms of biomolecules ranging from RNA and RNA-protein complexes, via large protein complexes to membrane proteins. Professor Harald Schwalbe from the BMRZ remarked: "We are very happy to have placed the order for the next generation of NMR. The 1.2 GHz NMR system will allow us to investigate structure, dynamics and biological function of increasingly large and challenging biomolecular complexes. We will also be able to provide access for European researchers."
Read More>>Calling it CO2“Capture Technology in a Bottle,” a team of researchers at GE’s Oil & GasTechnology Center in Oklahoma City, Oklahoma have been awarded close to $1million in Phase I funding by the U.S. Department of Energy’s National EnergyTechnology Laboratories (NETL) to plan and propose a large scale pilot testingof its CO2 Capture technology solution.“GE scientists have developed an innovative solution torealize both goals, which works well in the lab. Through this project, we willhave the opportunity to perform tests at a much larger scale to learn how tomake it work in a power plant.”GE chemists have developed a solution that effectivelyuses a class of amino silicone compounds at various temperatures to capturecarbon. These compounds are the same as those found in hair conditioners andfabric softeners. In hair products and washing machines, these compounds areused to soften your hair or clothing. GE is using them attach to andessentially wash out CO2 gas from a power plant flue stack.How it worksAt temperatures ofaround 105 degrees F, the amino silicone materials attach to CO2 gas. When theheat is increased another 100 degrees F, these materials release the carbon andcan then be re-used to capture more. One of the big advantages of GE’s technologyis that it does not require any water, which substantially reduces the energyrequired to capture the carbon.“For decades,scientists from around the world have focused their efforts on finding moreeffective, less expensive ways to reduce CO2 emissions in the atmosphere,” saidPhil DiPietro, Technical Manager, CO2 Capture and Separation, GE’s Oil and GasTechnology Center in Oklahoma City. “GE scientists have developed an innovativesolution to realize both goals, which works well in the lab. Through thisproject, we will have the opportunity to perform tests at a much larger scaleto learn how to make it work in a power plant.”Testing of GE’s newCO2 capture solution will take place at the CO2 Technology Center at Mongstad(TCM), Norway, which is the world’s largest industrial scale test facility.This $1 billion (USD) facility is fully instrumented and designed to providetechnology developers with an infrastructure to subject their technologies toall the stresses that real-time operations would entail. GE is partnering withthe CO2 Capture Centre in Mongstad.TCM Managing DirectorMr. Roy Vardheim said: “We are very satisfied that the close co-operationbetween the US and Norway now facilitates bringing leading technologies andcompanies to our world class testing arena at Mongstad. We are impressed withthe technological developments by our US partners, and are confident that theywill benefit from the unique qualities of the TEST facilities and services thatTCM will provide.As part of Phase 1funding, GE will advance planning of their Amino-silicone CO2 capturetechnology towards large scale pilot testing. It is expected that two of thesix phase 1 projects will be selected for Phase 2. The Phase 2 awards forconstruction and execution of pilot testing is anticipated by mid-2016. Thelarge scale testing will aim to demonstrate the technology at industrial scaleand provide final confidence in the maturity of the Carbon Capture technologyfor full scale commercial deployment, reducing emissions from power plants andother large industrial point sources of CO2.GE’s technologydevelopment taps into decades of expertise working with amino siliconematerials when GE operated a silicones business. The NETL project is part of adecade long joint cooperation between the US and Norwegian energy authoritieson CO2 Capture and Storage technologies. The co-operation between the US andNorwegian Energy authorities in the area of carbon capture and storage datesback to 2004, when the two governments signed a memorandum of understanding(MOU).
Read More>>A high-level meeting on Sino-German industrial cooperation held in the Sino-German Industrial Services Zone in Foshan in South China's Guangdong province on Sept 10 attracted over 500 participants, including officials, leading professors and company representatives from both sides.Mo Wei, office director of the Ministry of Industry and Information Technology, delivered the keynote speech at the meeting, titled "Made in China 2025 Meets German Industry 4.0”. He said that the conference provided a platform for both sides to promote mutual trust and in-depth cooperation at both the governmental and personal levels.The Sino-German Industrial Services Zone could make a positive contribution to Sino-German economic cooperation in this regard, he said.Wang Yueqin, director of the Guangdong Big Data Administrative Bureau, then introduced Guangdong province's achievements in the manufacturing and information industries. She later announced that five cities in China — Foshan, Jiangmen, Zhaoqing, Jieyang and Yunfu — had put forward a proposed "Sino-German City Alliance", with five industrial cities in Germany — Bremen, Hannover, Wuppertal, Osnabrück and Aachen.Ou Bangmin, secretary of the Sino-German Industrial Services Zone Party committee, stressed the importance of the "Sino-German City Alliance" proposal and said German companies such as Hannover Fairs China Ltd choosing to open branch offices in Foshan was helping to bring the local economy more in line with international practice.At a strategic meeting hosted in the manufacturing center of the Pearl River Delta, participants said the conference was conducive to upgrading Chinese corporations and the integration of traditional manufacturing with the modern service industry.
Read More>>
